Basic Information

                王  岩

               博士,副研究员

               博士研究生导师

        西安交通大学第二附属医院

                药学部  副主任

           陕西省青年科技新星

     西安交通大学“仲英青年学者”

  (交大每年遴选5人,医学部1人)

招生信息

博士研究生

100702药剂学

研究方向:04(全日制)药剂学 临床药学方向

 

硕士研究生(学术型)

1007Z2 药事管理学

研究方向:01(全日制)药事管理学

 

硕士研究生(专业型)

105500药学

研究方向:01(全日制)不分研究方向

Main Responsibility

中国药理学会治疗药物监测研究专业委员会 青年委员

“环境与疾病相关基因”教育部重点实验室 学术骨干

陕西省药理学会医疗机构制剂专委会 副主任委员

陕西省药学会青年工作委员会 常务委员

陕西省药理学会临床药理专业委员会 常务委员

《中国抗生素杂志》《中国感染控制杂志》青年编委

 

Honorary Title

2009-2013年 连续三年国家奖学金,专业第一

                   重庆市三好学生

                   重庆市优秀毕业生

2018年 西安交通大学优秀毕业生干部

Contact Information

地址:陕西省西安市新城区西五路157号

E-mail:wangyan0819@mail.xjtu.edu.cn

站点计数器

Research Fields

研究方向

重症患者个体化精准用药

  • 药物流行病学(循证药学及药物经济学)

  • 重症患者数据库挖掘

  • 机器学习方法与重症患者生物医学大数据

个人简介

主持国家自然科学基金2项:

①多源异构数据融合驱动的重症感染患者抗菌药物精准决策模型的构建及评价 (72274153,45万元);

②基于AFS策略导向的危重症患者抗真菌药物合理使用的决策模型构建与实证评价 (71904155,18.5万元)。

省级重点研发计划1项,省级创新能力支撑计划1项,西安交通大学第二附属医院“育英”计划-新星人选首批入选者(全院六位),其它纵向课题3项(现有在研经费>280万)

发表SCI文章46篇,其中第一作者或通讯作者17篇(其中9篇Q1,ESI高被引论文1篇)。

Work Experience

2024/05 – 至今       西安交通大学第二附属医院  药学部副主任 

2020/04 – 至今       西安交通大学第二附属院  副研究员

2019/03 –2020/04    西安交通大学第二附属院  助理研究员

Educational Experience

2013/09 – 2018/12 西安交通大学医学部药学院,博士,导师:董亚琳,专业:临床药学

2017/11– 2018/11 澳大利亚昆士兰大学药学院,博士联合培养,导师:Mieke van Driel, 专业:药物流行病学

2009/09 – 2013/07 西南大学药学院,学士

Publications

  1. Liu Y, Dai M, Zhang K, Zhang L, Lin B, Chen K, Wang H, Gu Z, Yu Y, Wang Yan*. Risk of Clostridioides difficile infection following different antibiotics: insights from multi-source medical data. Int J Antimicrob Agents. 2024 Jul 31;64(4):107288.(中科院医学2区)
  2. Zhang Li, Li Ping, Liu Chenwei, Zheng Qiwen, Wang Yan*. Low early anti-factor Xa target achievement rate of low molecular weight heparin for treating venous thromboembolism in intensive care unit patients. J Clin Pharmacol. 2023 Jun;63(6):664-671.
  3. Xing Yuanming, Qiu Yulan, Yang Luting, Yuan Zuyi, Wang Yan *. Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model. Int J Cardiol. 2023 Jan 15;371:420-426.(中科院医学2区)
  4. Xie J, Yang Q, Han X, Dong Y, Zhang T, Li Y, Ji M, Liu C, Cai Y, Wang Y*. Pharmacokinetic/Pharmacodynamic Target Attainment of Different Antifungal Agents in De-escalation Treatment in Critically Ill Patients: A Step toward Dose Optimization Using Monte Carlo Simulation. Antimicrob Agents Chemother. 2022 Jun 21;66(6): e0009922; (中科院药学1区)
  5. Wang Y*, Mieke L Van Driel, Treasure M McGuire, Samantha A Hollingworth. Trends in systemic antifungal use in Australia, 2005-2016: a time-series analysis. Jpn J Infect Dis. 2022 May 24;75(3):254-261;
  6. Han R, Teng M, Zhang Y, Zhang T, Wang T, Chen J, Li S, Yang B, Shi Y, Dong Y*, Wang Y*. Choosing Optimal Antibiotics for the Treatment of Patients Infected With Enterobacteriaceae: A Network Meta-analysis and Cost-Effectiveness Analysis. Front Pharmacol. 2021 Jun 17; 12:656790; (中科院药学2区)
  7. Wang Y, Zhang Y, TM McGuire, SA Hollingworth, ML Van Driel, Cao L, Wang X, Dong Y*. ICU patients' antibiotic exposure and triazole-resistance in invasive candidiasis: parallel analysis of aggregated and individual data. Front Pharmacol. 2021 Mar 22; 12:586893;(中科院药学2区)
  8. Wang Y#*, Zhong H#, Han X, Wang N, Cai Y, Wang H, Yu J, Zhang X, Zhang K*. Impact of antibiotic prescription on the resistance of Klebsiella pneumoniae at a tertiary hospital in China, 2012-2019. Am J Infect Control. 2021, 49(1): 65-69;
  9. Wang Y*, Treasure M McGuire, Samantha A Hollingworth, Dong Y, Mieke L Van Driel. Antifungal agents for invasive candidiasis in non-neutropenic critically ill adults: what do the guidelines recommend? Int J Infect Dis. 2019, 89: 137-145;(中科院医学2区)
  10. Wang Y, Xing Y, Chen L, Meng T, Li Y, Xie J, Chen L, Dong Y*, Dong W*. Fluconazole versus mould-active triazoles for primary antifungal prophylaxis in adult patients with acute lymphoblastic leukemia: clinical outcome and cost-effectiveness analysis. Int J Hematology, 2018, 107(2): 235-243
  11. Wang Y, Xie J, Xing Y, Chen L, Li Y, Meng T, Dong W, Wang X, Dong Y*. Choosing optimal antifungal agents to prevent fungal infections in nonneutropenic critically ill patients: trial sequential analysis, network meta-analysis, and pharmacoeconomic analysis. Antimicrob Agents Chemother, 2017, 61(12): e00620-17(中科院药学1区)
  12. Wang Y, Yang Q, Chen L, Liu L, Hao R, Zhang T, Wang X, Lei J, Xie J, Dong Y*. Cross-resistance between voriconazole and fluconazole for non-albicans Candida infection: a case-case-control study. Eur J Clin Microbiol Infect Dis, 2017, 36(11): 2117-2126
  13. Wang Y, Wang T, Xie J, Yang Q, Zheng X, Dong W, Xing J, Wang X, Dong Y*. Risk factors for voriconazole-associated hepatotoxicity in patients in the intensive care unit. Pharmacotherapy, 2016, 36(7): 757-765;(中科院医学2区)
  14. Wang Y, Zou Y, Xie J, Wang T, Zheng X, He H, Dong W, Xing J, Dong Y*. Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis. Eur J Clin Pharmacol, 2015, 71(1): 107-115
  15. Zhong H#, Wang Y#, Zhang Z, Liu Y, Le K, Cui M, Yu Y*, Gu Z*, Gao Y, Lin H*. Efficacy and safety of current therapeutic options for COVID-19 - lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis. Pharmacol Res. 2020, 157: 104872(中科院医学1区,ESI高被引)
  16. Zhang Y#, Wang Y#, Van Driel ML, McGuire TM, Zhang T, Dong Y, Liu Y, Liu L, Hao R, Cao L, Xing J, Dong Y*. Network meta-analysis and pharmacoeconomic evaluation of antibiotics for the treatment of patients infected with complicated skin and soft structure infection and hospital-acquired or ventilator-associated penumonia. Antimicrob Resist Infect Control, 2019, 8:72.(中科院医学2区)
  17. Zhang Li#, Wang Yan#, Ping Li, Wang Haitao, Cai Yan, Wang Na, Liu Chenwei, Fang Yu*. Impact of clinical pharmacist services on physicians' guideline compliance and prognosis of patients for venous thromboembolism prophylaxis in ICU. Int J Clin Pharmacol Ther. 2023 Jan;61:24-32.
  18. 王岩, 董亚琳, 张抗怀. 抗侵袭性念珠菌药物管理指标与治疗方案一致性对重症患者预后的影响.临床药物治疗杂志, 2021, 19(12): 45-48.
  19. 王海涛, 张抗怀, 谢姣, 王娜, 杨乾婷, 蔡艳, 李友佳, 张莉, 王岩*. 临床药师对重症监护室抗菌药物相关药物相互作用的研究及药学服务. 中国药师, 2023, 26 (10): 125-131.